StreetInsider.com News Articles

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

Tue, 21 Jul 2026 16:05:00 -0400

HAYWARD, Calif.--(BUSINESS WIRE)--

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced it will report business updates and financial results for the second quarter 2026 after market close on Thursday, August 6, 2026. Company management will host a corresponding conference call to discuss business updates beginning at 1:30pm PT / 4:30pm ET.

Investors interested in listening to the conference call may do so by dialing 1-800-715-9871 from the U.S. or 1-646-307-1963 internationally and providing Conference ID 3486060. A live and recorded webcast of

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

Tue, 21 Jul 2026 16:05:00 -0400

HAYWARD, Calif.--(BUSINESS WIRE)--

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

Tue, 21 Jul 2026 16:05:00 -0400

HAYWARD, Calif.--(BUSINESS WIRE)--

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

Tue, 21 Jul 2026 16:05:00 -0400

HAYWARD, Calif.--(BUSINESS WIRE)--

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wed, 15 Jul 2026 16:05:00 -0400

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to three new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issued on July 13, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).

Pulse has awarded inducement options to three new employees to purchase, in aggregate, up

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wed, 15 Jul 2026 16:05:00 -0400

Pulse has awarded inducement options to three new employees to purchase, in aggregate, up

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wed, 15 Jul 2026 16:05:00 -0400

Pulse has awarded inducement options to three new employees to purchase, in aggregate, up

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Wed, 15 Jul 2026 16:05:00 -0400

Pulse has awarded inducement options to three new employees to purchase, in aggregate, up

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: Zanganeh Mahkam

Mon, 15 Jun 2026 21:22:00 -0400

si-local-file:///var/storage/secattach/20260615/26649239.html

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: Zanganeh Mahkam

Mon, 15 Jun 2026 21:22:00 -0400

si-local-file:///var/storage/secattach/20260615/26649239.html

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: van den Broek Richard

Mon, 15 Jun 2026 21:07:00 -0400

si-local-file:///var/storage/secattach/20260615/26649215.html

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: van den Broek Richard

Mon, 15 Jun 2026 21:07:00 -0400

si-local-file:///var/storage/secattach/20260615/26649215.html

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: DUGGAN ROBERT W

Mon, 15 Jun 2026 21:06:00 -0400

si-local-file:///var/storage/secattach/20260615/26649212.html

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: DUGGAN ROBERT W

Mon, 15 Jun 2026 21:06:00 -0400

si-local-file:///var/storage/secattach/20260615/26649212.html

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: Soni Manmeet Singh

Mon, 15 Jun 2026 21:03:00 -0400

si-local-file:///var/storage/secattach/20260615/26649201.html

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: Soni Manmeet Singh

Mon, 15 Jun 2026 21:03:00 -0400

si-local-file:///var/storage/secattach/20260615/26649201.html

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: Sainz Maria

Mon, 15 Jun 2026 20:55:00 -0400

si-local-file:///var/storage/secattach/20260615/26649184.html

Form 4 PULSE BIOSCIENCES, INC. For: Jun 11 Filed by: Sainz Maria

Mon, 15 Jun 2026 20:55:00 -0400

si-local-file:///var/storage/secattach/20260615/26649184.html

Form 8-K PULSE BIOSCIENCES, INC. For: Jun 11

Fri, 12 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260612/26640700.html

Form 8-K PULSE BIOSCIENCES, INC. For: Jun 11

Fri, 12 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260612/26640700.html

Form 8-K PULSE BIOSCIENCES, INC. For: Jun 10

Wed, 10 Jun 2026 08:55:00 -0400

si-local-file:///var/storage/secattach/20260610/26627430.html

Form 8-K PULSE BIOSCIENCES, INC. For: Jun 10

Wed, 10 Jun 2026 08:55:00 -0400

si-local-file:///var/storage/secattach/20260610/26627430.html

Pulse Biosciences plans warrant redemption after stock price trigger

Wed, 10 Jun 2026 07:01:07 -0400

Pulse Biosciences Inc. (NASDAQ: PLSE) announced it will redeem remaining warrants from its 2024 rights offering after meeting required stock price conditions. The company plans to deliver a redemption notice around June 10, 2026, for warrants that can be exercised until July 13, 2026, at $11.00 per share.

The redemption became possible after the company's volume weighted average price exceeded $22.00 per share for twenty consecutive trading days, with an average of $25.17 during that period. Warrants not exercised by the July deadline will be redeemed for $0.01 per warrant.

The bioelectric medicine company received $60 million from its July 2024 rights

Pulse Biosciences plans warrant redemption after stock price trigger

Wed, 10 Jun 2026 07:01:07 -0400

The bioelectric medicine company received $60 million from its July 2024 rights

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Wed, 10 Jun 2026 07:00:00 -0400

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that it intends to deliver an irrevocable notice of redemption, on or about June 10, 2026, to redeem the remaining common stock warrants issued by the Company as part of its July 3, 2024 rights offering. These outstanding common stock warrants (the “200% Warrants”), which were issued in the Company’s 2024 rights offering (the “Rights Offering”), pursuant to the Company’s Registration Statement on Form S-3, as amended (File No. 333-278494), may be